Nordea Investment Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$671M Buy
1,447,549
+362,959
+33% +$183M 0.63% 34
2025
Q4
$507M Buy
1,084,590
+108,849
+11% +$50.5M 0.44% 45
2025
Q3
$416M Buy
975,741
+47,960
+5% +$18.6M 0.36% 62
2025
Q2
$350M Buy
927,781
+59,163
+7% +$21.3M 0.33% 80
2025
Q1
$300M Buy
868,618
+24,854
+3% +$7.99M 0.32% 87
2024
Q4
$253M Buy
843,764
+193,075
+30% +$67.5M 0.26% 105
2024
Q3
$263M Sell
650,689
-14,762
-2% -$5.4M 0.3% 92
2024
Q2
$218M Buy
665,451
+71,998
+12% +$23.4M 0.26% 110
2024
Q1
$197M Buy
593,453
+15,274
+3% +$4.67M 0.23% 119
2023
Q4
$157M Sell
578,179
-27,752
-5% -$6.86M 0.2% 139
2023
Q3
$150M Buy
605,931
+6,368
+1% +$1.74M 0.21% 131
2023
Q2
$182M Buy
599,563
+33,939
+6% +$9.44M 0.25% 113
2023
Q1
$148M Buy
565,624
+4,695
+0.8% +$1.19M 0.22% 126
2022
Q4
$133M Sell
560,929
-250,632
-31% -$56.1M 0.21% 132
2022
Q3
$153M Buy
811,561
+32,206
+4% +$6.42M 0.25% 117
2022
Q2
$130M Buy
779,355
+167,353
+27% +$36M 0.19% 139
2022
Q1
$156M Buy
612,002
+36,017
+6% +$9.04M 0.2% 133
2021
Q4
$148M Buy
575,985
+4,962
+0.9% +$1.21M 0.18% 144
2021
Q3
$144M Buy
571,023
+10,580
+2% +$2.59M 0.19% 143
2021
Q2
$116M Buy
560,443
+17,668
+3% +$3.6M 0.16% 163
2021
Q1
$103M Sell
542,775
-31,402
-5% -$5.54M 0.15% 159
2020
Q4
$94.4M Buy
574,177
+55,115
+11% +$8.06M 0.15% 158
2020
Q3
$64.9M Sell
519,062
-628,554
-55% -$77.8M 0.12% 164
2020
Q2
$108M Buy
1,147,616
+631,592
+122% +$65.7M 0.11% 163
2020
Q1
$46.4M Buy
516,024
+4,649
+0.9% +$602K 0.11% 158
2019
Q4
$75.6M Buy
511,375
+6,578
+1% +$883K 0.15% 133
2019
Q3
$60.1M Buy
504,797
+33,518
+7% +$4.33M 0.13% 149
2019
Q2
$63.7M Buy
471,279
+94,649
+25% +$12M 0.14% 141
2019
Q1
$49.1M Buy
376,630
+74,713
+25% +$10M 0.1% 171
2018
Q4
$37.6M Buy
301,917
+153,755
+104% +$20.6M 0.09% 176
2018
Q3
$20.6M Sell
148,162
-3,136
-2% -$390K 0.04% 275
2018
Q2
$15.5M Buy
151,298
+34,292
+29% +$3.47M 0.04% 274
2018
Q1
$11.3M Buy
117,006
+28,740
+33% +$2.79M 0.03% 290
2017
Q4
$7.75M Sell
88,266
-1,338
-1% -$107K 0.02% 344
2017
Q3
$7.13M Buy
89,604
+1,074
+1% +$86.4K 0.02% 358
2017
Q2
$7.72M Sell
88,530
-106
-0.1% -$8.97K 0.02% 312
2017
Q1
$7.89M Sell
88,636
-41,623
-32% -$3.47M 0.02% 293
2016
Q4
$9.64M Buy
130,259
+4,157
+3% +$311K 0.03% 271
2016
Q3
$9.54M Buy
126,102
+11,124
+10% +$852K 0.02% 267
2016
Q2
$8.85M Buy
114,978
+2,992
+3% +$236K 0.02% 253
2016
Q1
$8.74M Buy
111,986
+2,625
+2% +$183K 0.03% 250
2015
Q4
$7.4M Buy
109,361
+69,962
+178% +$4.88M 0.03% 247
2015
Q3
$3.05M Buy
39,399
+2,999
+8% +$266K 0.01% 271
2015
Q2
$3.3M Hold
36,400
0.01% 274
2015
Q1
$2.74M Buy
36,400
+4,100
+13% +$294K 0.01% 294
2014
Q4
$2.37M Buy
32,300
+9,580
+42% +$673K 0.01% 346
2014
Q3
$1.6M Buy
22,720
+7,986
+54% +$528K 0.01% 416
2014
Q2
$831K Hold
14,734
﹤0.01% 584
2014
Q1
$774K Buy
14,734
+2,834
+24% +$141K ﹤0.01% 596
2013
Q4
$568K Hold
11,900
﹤0.01% 648
2013
Q3
$509K Hold
11,900
﹤0.01% 670
2013
Q2
$429K Buy
+11,900
New +$460K ﹤0.01% 709

Other funds holding HCA